At Nemosia, we develop 1st in class radiopharmaceuticals for early detection of neurodegenerative disorders.
We aim to raise public awareness of neurological disorders and promote a culture where it is seen as normal and safe to do regular brain check-ups even if there are no visible symptoms.
We are the missing piece in the fight against neurodegeneration: the world's first Positron Emission Tomography (PET) Tracer targeting the NMDA receptor We believe in a world where PET scans for the early detection of neurodegeneration are regarded as a normal part of one's regular health checkup routine.Awa Diagne, CEO PET images showing a negative…